CompletedNot Applicable

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)

France80 participantsStarted 2019-04-23

Plain-language summary

Suspension laryngoscopy is realised during apnea. In effect, surgeons are in the mouth of the patient and we can't have access at the aiways. So investigators like to use a Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) to increase time of apnea and decrease the impact of oxygen desaturation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * suspension laryngoscopy Exclusion Criteria: * THRIVE contraindication: * epistaxis * undrained pneumothorax * Recent gastroesophageal surgery (1months) * Skull Fractures

What they're measuring

desaturation defined as the number of patient who presented at least one desaturation during suspension laryngoscopy

Timeframe: Two hours

Trial details

NCT IDNCT03843580

SponsorUniversity Hospital, Caen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-02-10

View on ClinicalTrials.gov More Apnea, Postanesthetic trials